Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Relaxation Potion Warning: Wake Up Call About FDA Beverage Guidance

This article was originally published in The Tan Sheet

Executive Summary

FDA warning letter on Dewmar’s Lean Slow Motion…Potion line is the first addressing differences between products marketed as conventional beverages and as liquid supplements since a final guidance in January. Attorney Justin Prochnow says the warning could signal an FDA crackdown on melatonin in conventional beverages.

You may also be interested in...



Industry Roundup: FPLA changes; Nutroganics in soy market; spiked product, supplement-beverage warnings; Kamil chairs CRN

FPLA changes proposed; Nutroganics invests to reach soy market; Shoreside hits spiked ingredient trifecta; NYSW blurs supplement-beverage line; Kamil elected CRN chair; and more news in brief.

Industry Roundup: FPLA changes; Nutroganics in soy market; spiked product, supplement-beverage warnings; Kamil chairs CRN

FPLA changes proposed; Nutroganics invests to reach soy market; Shoreside hits spiked ingredient trifecta; NYSW blurs supplement-beverage line; Kamil elected CRN chair; and more news in brief.

Whole Food Supplement Sales Growing Twice As Fast As Overall Category

Whole food supplement sales grew twice as fast as the overall supplement category in 2013, and could be the key to retaining and gaining sales in an industry that analysts predict will stagnate in the next few years as consumers opt for fortified “real” foods over supplements.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS106843

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel